CoChat

The Use of Probiotics in Gastrointestinal Disease

Open access
Madsen, Karen L · 2001 · Canadian Journal of Gastroenterology
Cited by 125

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Probiotics are living microorganisms that can affect the host in a beneficial manner. Prebiotics are nondigestible food ingredients that stimulate the growth and activity of probiotic bacteria already established in the colon. Efficacy of probiotic compounds has been shown in a wide range of gastrointestinal diseases.Lactobacillus GG alone, or the combination of Bifidobacterium bifidum and Streptococcus thermophilus,is effective in the treatment of Clostridium difficile,as well as in preventing the frequency and severity of infectious acute diarrhea in children. Prevention of antibiotic-induced diarrhea with the concomitant administration of either Lactobacillus GG or Saccharomyces boulardii has been demonstrated. The most successful studies involve the use of Lactobacillus GG at a dose of 1×10 10 viable organisms per day and the yeast boulardii at a dose of 1 g/day. A probiotic preparation (VSL#3 - 6 g/day) that uses a combination of three species of Bifidobacterium, four strains of Lactobacillus and one strain of Streptocccus has shown promise in maintaining remission in ulcerative colitis and pouchitis, as well as in preventing the postoperative recurrence of Crohn's disease. The mechanism of action of probiotics may include receptor competition, effects on mucin secretion or probiotic immunomodulation of gut-associated lymphoid tissue. Oral administration of probiotic compounds has been demonstrated to be well tolerated and safe. However, while probiotics have the potential to improve human health and to prevent and treat some diseases, major improvements are needed in labelling and quality assurance procedures for probiotic compounds. In addition, well planned and controlled clinical studies are necessary to delineate fully the potential for probiotic compounds.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2001/690741

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • The indigenous gastrointestinal microflora

    Berg, R. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10057-3 · Cited by 1,153 · cited 1×

    “At least three major bacterial habitats have been described: the lumen of the gastrointestinal tract, the mucus gel that overlies the epithelium and the adherence of bacteria to receptors on mucosal epithelial cells (6).”
    Background
  • Lactobacillemia in liver transplant patients

    Patel, R., Cockerill, F. R., Porayko, M. K., Osmon, D. R., Ilstrup, D. M., & Keating, M. R. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.207 · Cited by 100 · cited 1×

    “These infections have occurred in immunocompromised patients with aplasia (40), organ transplantation (41) and human immunodeficiency virus infection (42,43).”
    Background
  • Lactobacillemia in three patients with AIDS

    Horwitch, C. A., Furseth, H. A., Larson, A. M., Jones, T. L., Olliffe, J. F., & Spach, D. H. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1460 · Cited by 78 · cited 1×

    “These infections have occurred in immunocompromised patients with aplasia (40), organ transplantation (41) and human immunodeficiency virus infection (42,43).”
    Background
  • Lactobacillus Species as Opportunistic Pathogens in Immunocompromised Patients

    Schlegel, L., Lemerle, S., & Geslin, P. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050216 · Cited by 69 · cited 1×

    “These infections have occurred in immunocompromised patients with aplasia (40), organ transplantation (41) and human immunodeficiency virus infection (42,43).”
    Background

Show all 4 references

Cited by

Metadata

Authors
Madsen, K. L.
Venue
Canadian Journal of Gastroenterology
Publisher
Wiley
Published
2001
Volume
15
Issue
12
Pages
817-822
ISSN
0835-7900 (ISSN-L)
OpenAlex
W59050749
Cited by
125
References
4
FWCI
18.49
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.